COMMENTARY

• COMMENTARY／Thinking about Why Megapharmas Are Closing Research Labs in Japan
  November 24, 2008

• COMMENTARY／Marriage of Nos. 1 and 2 Wholesalers Creates Sensation in Market
  November 3, 2008

• COMMENTARY／Competition Intensifies for Development of DPP-4 Inhibitors
  September 22, 2008

• COMMENTARY／Yamato Searches for a Way to Start Generics Distribution Business
  September 22, 2008

• COMMENTARY／Reform of Ethical Drug Distribution Practices
  September 1, 2008

• COMMENTARY／Gov't to Cut Social Security Spending by \220 Bil by Promoting Use of Generics
  August 25, 2008

• COMMENTARY／Development Race for RNAi Therapeutics Heating Up in Japan
  August 4, 2008

• COMMENTARY 4 articles
  July 28, 2008

• COMMENTARY／Industry Needs More Creative Thinking: NHI Pricing System Reform
  July 21, 2008

• COMMENTARY／Will Fiscal Rehabilitation Policy Be Maintained?
  July 7, 2008

• COMMENTARY／Daiichi Sankyo Surprises the World by Announcing Acquisition of Ranbaxy
  June 30, 2008

• Pharmaceutical Partnerships in Japan for Regulatory and Commercial Success
  June 30, 2008

• COMMENTARY 4 articles
  June 9, 2008

• COMMENTARY／Shaking Pharmaceutical Administration System
  May 19, 2008

• COMMENTARY／Personnel Strategy -New Graduates or Work-Ready MRs?
  April 21, 2008

• COMMENTARY／Industry-Academia Cooperation Essential for Practical Use of iPS Cells
  April 21, 2008

• COMMENTARY／Improvement of Drug Distribution Business Practices Goes into Crucial Stretch
  April 14, 2008

• COMMENTARY／Mr Kodama Owes His Sweeping Victory to Members' Desire for Change: JPA
  March 31, 2008

• COMMENTARY／Most Mainstay Products Avoid Deep Price Cuts in FY2008 NHI Price Revision
  March 31, 2008

• Methodologic Issues in the Clinical Trial Study of Depression
  March 24, 2008

ページ